reported that some growth factor receptor-driven cancers resort to LPCAT1 to remodel the plasma membrane composition through accumulation of phospholipids, which in turn is required for transduction of oncogenic pathways such as EGFRvIII signaling (31). This evidence concerns the gene LPCAT1 and cancer.